technical analysis

Take It easy, take it easy. Don’t let the sound of your own wheels drive you crazy.

The Eagles

We are at a cusp in trading history, highlighted by the announcement of CME Groups (CME) most recent quarterly report. Three things stand out, considering the CME announcement:

CME killed the regulator/market committees LIBOR replacement. CME necessarily takes a completely different approach to data sales from the other major exchange management firms, which analysts dont get. CME is in grave danger of being converted from a public corporation to a public utility.

All these aspects of the CMEs report are positive for the stock.

technical analysis: Luxoft Holding, Inc.(LXFT)

Advisors’ Opinion:

  • [By Steve Symington]

    Luxoft Holding(NYSE:LXFT)announced strong fiscal fourth-quarter results on Monday, after the market closed. Similar to its modest post-earnings drop in February, shares of the software development specialist fell 3.6% on Tuesday as investors absorbed the news.

technical analysis: Dell Technologies Inc. (DVMT)

Advisors’ Opinion:

  • [By Lee Jackson]

    Avery familiar technology face was acquiring shares of Dell Technologies Inc. (NASDAQ: DVMT) last week. The legendary Michael Dell himself was purchasedshares in the newest incarnation of the famed Dell franchise. Heacquired a total of 254,545 shares at a very reduced price of $27.50, which could be option-related. The total for the trade was posted at $7 million.

technical analysis: Pure Cycle Corporation(PCYO)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Tuesday, utilities shares fell 0.46 percent. Meanwhile, top losers in the sector included Korea Electric Power Corporation (ADR) (NYSE: KEP), down 4 percent, and Pure Cycle Corporation (NASDAQ: PCYO), down 2 percent.

  • [By Jim Robertson]

    On Wednesday, our Under the Radar Moversnewsletter suggested small cap water and wastewater services stockPure Cycle Corporation (NASDAQ: PCYO) as a long/bullish trade:

technical analysis: Continental Resources, Inc.(CLR)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    While crude prices stumbled into 2016, they found their footing by mid-year and roared back to life, ending the year up about 42%. Those rising prices lifted most oil stocks. However, a handful of large-cap oil stocks rose above the crowd by outperforming crude’s rally. Those top-tier performers wereContinental Resources (NYSE:CLR), Devon Energy (NYSE:DVN), Anadarko Petroleum (NYSE:APC), Pioneer Natural Resources (NYSE:PXD), and Cimarex Energy (NYSE:XEC):

  • [By Ben Levisohn]

    Beta Should Lead At The Start of A Rally: Best ideas in the first leg up: Marathon Oil, Devon Energy (DVN), Anadarko Petroleum (APC), and Continental Resources (CLR). If OPEC announces a cut, whether moderate or deep, we expect that in the initial move up, moderate value beta names, like Marathon Oil, Devon Energy, Anadarko Petroleum, andContinental Resources will lead.For a $5 increase in oil prices, we estimate 2017 cash flow per share would increase 12-18% for these stocks vs. the remainder of the group at 12%. Of these four, short interest is modest for all exceptContinental Resources at 25%, among the highest in our universe. Outperformance of these names should be driven by investors adding to long positions, not short covering.

  • [By WWW.THESTREET.COM]

    There has also been a chorus of voices opposing the Paris agreement as well. Twenty-two Republican Senators last week signed a letter calling for the U.S. to withdraw. On the corporate front, Harold Hamm, the CEO of Continental Resources (CLR) and adviser to the Trump campaign, in a letter to Trump ahead of his inauguration reported by the New York Times called on the president to “cancel” the Paris treaty.

technical analysis: Flowserve Corporation(FLS)

Advisors’ Opinion:

  • [By Damon Churchwell]

    Increasing sales and margins
    A second, even larger, flow technology company to consider is Flowserve (NYSE: FLS  ) . The company’s flow control systems are utilized by a wide range of industries, led by oil & gas, chemicals, and power generation.

technical analysis: Aphria Inc. (APHQF)

Advisors’ Opinion:

  • [By Javier Hasse]

    Also quite recently, Benzinga asked Alan Brochstein, founding partner at New Cannabis Ventures and founder at 420 Investor, about plays in the marijuana industry against such an uncertain backdrop. The expert mentioned a few Canadian Licensed Producers, including AURORA CANNABIS IN COM NPV (OTC: ACBFF), APHRIA INC NPV (OTC: APHQF), METTRUM HEALTH COR COM NPV (OTC: MQTRF), ORGANIGRAM HLDGS I COM NPV (OTC: OGRMF), SUPREME PHARMACEUT COM NPV (OTC: SPRWF) and CANOPY GROWTH CORP COM NPV (OTC: TWMJF), as well as “the only” biotech stock in the space, GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH).

  • [By Sean Williams]

    This rapid growth in legal pot has create quite the demand for marijuana stocks. The seven largest marijuana stocks by market cap have all put on a show over the past couple of years. Here are those seven “green giants” listed with their market caps as of March 17, 2017, along with their trailing one-year total returns.

    GW Pharmaceuticals (NASDAQ:GWPH): $3.0 billion, up 64% Canopy Growth Corp. (NASDAQOTH:TWMJF): $904 million, up 259% Aphria (NASDAQOTH:APHQF) $440 million, up 381% Aurora Cannabis (NASDAQOTH:ACBFF): $482 million, up 299% AXIM Biotechnologies (NASDAQOTH:AXIM): $562 million, up 1,720% Corbus Pharmaceuticals (NASDAQ:CRBP): $450 million, up 431% Medical Marijuana (NASDAQOTH:MJNA): $221 million, up 254%

    As you can see, these are some hefty valuations — and some exceptionally strong moves higher on the heels of marijuana’s expansion. With the exception of GW Pharmaceuticals, every one of the largest marijuana stocks has at least tripled in value over the trailing 12 months, with cannabinoid-based drug developer AXIM Biotechnologies skyrocketing more than 1,700%!

  • [By Javier Hasse]

    While biotechs like GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH) and Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) only lost 0.45 percent and 0.36 percent respectively, other companies experienced a large tumble. CANOPY GROWTH CORP COM NPV (OTC: TWMJF) lost 4.71 percent, AURORA CANNABIS IN COM NPV (OTC: ACBFF) slipped 2.93 percent, APHRIA INC COM NPV (OTC: APHQF) dropped 1.01 percent, and MassRoots Inc (OTC: MSRT) plummeted an astounding 9.00 percent.

  • [By Keith Speights]

    As increasingly more marijuana growers entered the market and more states allowed residents to legally grow marijuana, cannabis prices dropped throughout 2016. Wholesale marijuana prices late in the year were roughly half the levels of 12 months earlier. Will this trend continue — and possibly hurt leading marijuana stocks including Aphria (NASDAQOTH:APHQF),Aurora Cannabis (NASDAQOTH:ACBFF), Medical Marijuana,Inc.(NASDAQOTH:MJNA), and even GW Pharmaceuticals (NASDAQ:GWPH) in the process?

  • [By Keith Speights]

    There are plenty of reasons for investors to like three marijuana stocks in particular — GW Pharmaceuticals (NASDAQ:GWPH), Insys Therapeutics (NASDAQ:INSY), and Aphria (NASDAQOTH:APHQF). In fact, there are at least 661 million reasons. That’s the amount of cash in U.S. dollars that the three companies have combined. Here’s why the cash stockpiles held by GW, Insys, and Apria are important.

  • [By SEEKINGALPHA.COM]

    Some of you may have seen the joint press release this morning from Aphria Inc. (OTCQB:APHQF) and Liberty Health Sciences Inc. (OTCPK:SCQBD) regarding their response to TMX Group’s “regulatory engagement.” Some people contacted us asking questions like how are the two companies related?, and more. Don’t worry – we’ve got you covered!

Leave a Reply

Your email address will not be published. Required fields are marked *